Category: New products
-
Start-Up Developing Blood-Brain Barrier Treatments
A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier.
-
3-D Printing Devised for Sensors in Soft Robotics
Engineering researchers developed techniques using three-dimensional printing that enables robotic devices made with soft materials, like those in health care, to sense more properties of objects they encounter.
-
Techniques Devised to Boost Gene Therapy Success
An engineering team at Washington University in St. Louis is developing mechanical and electronic processes to improve the success of inserting large, complex therapeutic molecules like DNA into cells.
-
Protein Engineered to Boost Nerve Cell Imaging
Engineers and neuroscientists developed a synthetic protein that illuminates electrical activity in animal brain nerve cells, with a process using robotics to test millions of protein candidates in cells.
-
Quick, Portable Soil Pathogen Test Process Developed
A university plant science lab developed techniques with readily-available components and materials that make detecting destructive microbes in farm soil faster and easier.
-
Trials Test Antibodies to Prevent Hospital Infections
Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics.
-
A.I./Image Analysis Diagnose Eye, Lung Diseases
Researchers developed more efficient computational tools with artificial intelligence (A.I.) to diagnose retinal diseases and pneumonia by analyzing retinal scans and X-ray images.
-
Highly Stretchable Sensors Devised for Wearable Devices
Engineers in Canada developed graphene sensors with a great deal of flexibility that can measure fine human movements and minute functions for wearable medical devices, and be made with an economical process.
-
Precision Cancer Drug Shown Effective in Adults, Children
Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs.
-
RNA Vaccine Shows Promise with Infant Viral Diseases
A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients.